Tango Therapeutics, Inc.TNGXNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 8 | 37↑383.8% | 25↓32.9% | 37↑46.9% | 42↑15.2% |
| Gross Profit | 6 | 37↑514.2% | 25↓32.9% | 37↑46.9% | 42↑15.2% |
| Operating Income | -52 | -58↓11.5% | -111↓90.9% | -114↓2.8% | -146↓27.5% |
| Net Income | -52 | -58↓12.1% | -108↓85.8% | -102↑5.9% | -130↓28.1% |
| EBITDA | -50 | -57↓13.8% | -109↓91.1% | -112↓2.1% | -143↓28.0% |
| EPS Diluted | -1.62 | -0.94↑42.0% | -1.23↓30.9% | -1.08↑12.2% | -1.19↓10.2% |